< 回列表
Loong Herbert Ho Fung
- Associate Professor (Clinical) – Department of Clinical Oncology
The Precision Roadmap: Navigating the New Era of HER2-Mutated NSCLC Therapy
| 角色 | 講師 |
| 日期時間 | 05/02 14:50 - 15:30 |
| 地點 | 701B |
學歷 / 訓練
2018
OTHERS
Fellow (By Nomination), Royal Colleges of Physicians of Edinburgh, United Kingdom
2016
OTHERS
Postgraduate Diploma in Molecular & Diagnostic Pathology, The University of Hong Kong
2013
OTHERS
Clinical Research Fellowship, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Canada
專業與研究經歷
2021
- Present
Department of Clinical Oncology, The Chinese University of Hong Kong
2025
- Present
Phase 1 Clinical Trial Centre, The Chinese University of Hong Kong
獲獎與榮譽
2024
Fellow of the American Society of Clinical Oncology (FASCO), ASCO
2019
Best Poster Award, European Society of Medical Oncology Asia (ESMO Asia) Congress 2019, Singapore
2018
IASLC Foundation Cancer Care Team Award – Awarded for “Best Thoracic Cancer Care in Asia & Rest of World” 2018, International Association for the Study of Lung Cancer **Prestigious international award nominated by lung cancer patients and their caregivers. The CUHK team led by Loong HH received over 10 individual nominations and was bestowed this award for leading the best thoracic cancer care team within the geographical category of “Asia & Rest of World”
重要出版品
- Lam CS, Hua R, Au-Doung LW, Wu YK, Koon HK, Zhou KR, Loong HH, Chung VC, Lee R, Chan A, Cheung YT. Potential supplement-drug interactions and bleeding in patients with cancer: A UK Biobank study. J Integr Med. 2026 Jan;24(1):90-97. d